Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study.
Castro NM, Moura F, Hada AL, Garcia D, Victor EDS, Schvartsman G, Carvalho L, Fernandes MLC, Martins RS, Silva EFD, Santos SSMBD, Taniwaki L, Taranto P, Pontes J, Beal JR, Dutra ACP, Oliveira Filho JB, Araujo SEA, Usón Junior PLS.
Castro NM, et al. Among authors: hada al.
Einstein (Sao Paulo). 2024 Jun 24;22:eAO0575. doi: 10.31744/einstein_journal/2024AO0575. eCollection 2024.
Einstein (Sao Paulo). 2024.
PMID: 38922219
Free PMC article.